nevena damjanov, md, shares thoughts on the role of systemic therapy in hcc
Published 5 years ago • 229 plays • Length 0:34
Download video MP4
Download video MP3
Similar videos
-
0:46
nevena damjanov, md, outlines the role of tace with systemic therapy in hcc patients
-
0:49
nevena damjanov, md, regarding the impact of the redos study in hcc
-
1:02
nevena damjanov, md, shares the latest news in systemic therapy for advanced hcc at asco 2018
-
0:47
nevena damjanov, md, discusses identifying subgroups of patients for targeted therapies in hcc
-
1:13
nevena damjanov, md, comments on identifying subgroups of patients for targeted therapies in hcc
-
1:47
nevena damjanov, md, discusses how new agents for advanced hcc will be integrated into the treatment
-
1:16
nevena damjanov, md, discusses current treatment options and sequencing tkis in hcc
-
0:35
nevena damjanov, md, on the use of pembrolizumab in hcc patients previously treated with sorafenib
-
1:05:27
oligometastases: an evolving frontier in radiation oncology
-
5:40
sorafenib initiation after tace in hcc
-
6:15
vision to heal, together: a collaborative approach to cancer care
-
0:35
nevena damjanov, md, elaborates on stereotactic body radiation therapy in early stage hcc
-
0:54
nevena damjanov, md, regarding sequencing tkis in hepatocellular carcinoma (hcc)
-
0:43
nevena damjanov, md, on combining cabozantinib with checkpoint inhibitors in advanced hcc patients
-
0:36
nevena damjanov, md, on the outcomes of combining atezolizumab with bevacizumab in hcc patients
-
1:14
nevena damjanov, md, on the phase 3 checkpoint 459 trial studying nivolumab in hcc
-
0:49
nevena damjanov, md, considers the shortcomings of recist in measuring efficacy in hcc patients
-
0:37
nevena damjanov, md, on whether regorafenib will be integrated into clinical practice
-
1:01
nevena damjanov, md, explains how checkpoint inhibitors will be incorporated into the treatment
-
1:29
nevena damjanov, md, shares her impressions of lenvatinib data in 1st line uhcc presented at asco
-
0:39
nevena damjanov, md, explains the outcomes of the resorce trial as presented here at asco gi 2017
-
1:00
nevena damianov, md illustrates the promising classes and products for advanced, unresectable hcc
Clip.africa.com - Privacy-policy